A Phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous A6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer

S. A. Ghamande, M. Silverman, M. Gold

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'A Phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous A6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer'. Together they form a unique fingerprint.